Controversies in the management of adjuvant breast cancer with taxanes: Review of the current literature

被引：17

作者：

Araque Arroyo, Patricia ^{[1
]}

Ubago Perez, Ruth ^{[1
]}

Cancela Diez, Barbara ^{[1
]}

Fernandez Feijoo, Maria Amalia ^{[1
]}

Hernandez Magdalena, Jorge ^{[1
]}

Hernandez, Miguel Angel Calleja ^{[1
]}

机构：

[1] Virgen Nieves Univ Hosp, Dept Pharm, Granada 18012, Spain

来源：

CANCER TREATMENT REVIEWS | 2011年 / 37卷 / 02期

关键词：

Adjuvant breast cancer; Docetaxel; Paclitaxel; Taxanes; Therapy; DOXORUBICIN PLUS CYCLOPHOSPHAMIDE; PHASE-III; DOSE-DENSE; CHEMOTHERAPY; PACLITAXEL; DOCETAXEL; EPIRUBICIN; TRIAL; THERAPY; FLUOROURACIL;

D O I：

10.1016/j.ctrv.2010.06.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Taxanes offer clear benefits in adjuvant chemotherapy for early breast cancer. This review examines evidence to date on the clinical effectiveness and cost-effectiveness of their use in the adjuvant treatment of women with early breast cancer, based on three meta-analyses, one systematic review, five clinical practice guidelines and 16 randomized clinical trials. Against the background of a major increase in the use of docetaxel rather than paclitaxel in our setting over the past few years, implying a major increase in costs, we examined whether this higher use of docetaxel is supported by the available evidence. In this wide study, we found no evidence that regimens containing docetaxel yield greater benefits than those including paclitaxel. From an effectiveness standpoint, the change from paclitaxel to docetaxel in our setting is not justified. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：105 / 110

页数：6

共 26 条

[1]

[Anonymous], NCCN CLIN PRACT GUID

[2]

*BC AG, 2007, BC AG 2007 GUID

[3]

Bianco AR, 2006, J CLIN ONCOL, V24, p8S

[4] Benefit of taxanes as adjuvant chemotherapy for early breast cancer - Pooled analysis of 15,500 patients [J].

Bria, Emilio ;

Nistico, Cecilia ;

Cuppone, Federica ;

Carlini, Paolo ;

Ciccarese, Mariangela ;

Milella, Michele ;

Natoli, Guido ;

Terzoli, Edmondo ;

Cognetti, Francesco ;

Giannarelli, Diana .

CANCER, 2006, 106 (11) :2337-2344

[5] Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer [J].

Burnell, Margot ;

Levine, Mark N. ;

Chapman, Judith-Anne W. ;

Bramwell, Vivien ;

Gelmon, Karen ;

Walley, Barbara ;

Vandenberg, Ted ;

Chalchal, Haji ;

Albain, Kathy S. ;

Perez, Edith A. ;

Rugo, Hope ;

Pritchard, Kathleen ;

O'Brien, Patti ;

Shepherd, Lois E. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :77-82

[6]

Buzdar AU, 2002, CLIN CANCER RES, V8, P1073

[7] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[8] Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials [J].

De Laurentiis, Michele ;

Cancello, Giuseppe ;

D'Agostino, Diego ;

Giuliano, Mario ;

Giordano, Antonio ;

Montagna, Emilia ;

Lauria, Rossella ;

Forestieri, Valeria ;

Esposito, Angela ;

Silvestro, Lucrezia ;

Pennacchio, Roberta ;

Criscitiello, Carmen ;

Montanino, Agnese ;

Limite, Gennaro ;

Bianco, Angelo Raffaele ;

De Placido, Sabino .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) :44-53

[9] Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial [J].

Ellis, Paul ;

Barrett-Lee, Peter ;

Johnson, Lindsay ;

Cameron, David ;

Wardley, Andrew ;

O'Reilly, Susan ;

Verrill, Mark ;

Smith, Ian ;

Yarnold, John ;

Coleman, Robert ;

Earl, Helena ;

Canney, Peter ;

Twelves, Chris ;

Poole, Christopher ;

Bloomfield, David ;

Hopwood, Penelope ;

Johnston, Stephen ;

Dowsett, Mitchell ;

Bartlett, John M. S. ;

Ellis, Ian ;

Peckitt, Clare ;

Hall, Emma ;

Bliss, Judith M. .

LANCET, 2009, 373 (9676) :1681-1692

[10] Taxanes for adjuvant treatment of early breast cancer [J].

Ferguson, T. ;

Wilcken, N. ;

Vagg, R. ;

Ghersi, D. ;

Nowak, A. K. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)

← 1 2 3 →